Table 1:
Supervised Treadmill Exercise Therapy (SET) (N=153) | Attention Control (N=156) | |
---|---|---|
Age (years) | 68.31 (9.12) | 67.56 (9.50) |
Female sex, N (%) | 66 (43.14) | 66 (42.31) |
Black race, N (%) | 87 (56.86) | 98 (62.82) |
Ankle brachial index | 0.66 (0.18) | 0.66 (0.18) |
Body mass index (kg/M2) | 30.46 (6.31) | 30.33 (6.92) |
Current smoker, N (%) | 51 (33.33) | 47 (30.13) |
Diabetes mellitus, N (%) | 56 (36.60) | 62 (39.74) |
Coronary artery disease, N (%) | 48 (31.37) | 39 (25.00) |
Pulmonary disease, N (%)* | 15 (9.80) | 22 (14.29) |
Heart failure, N (%)* | 13 (8.61) | 25 (16.03) |
Classic Intermittent Claudication Symptoms, N (%) | 54 (35.29) | 47 (30.13) |
Asymptomatic, N (%) | 8 (5.23) | 6 (3.85) |
Prior lower extremity revascularization, N (%) | 50 (32.68) | 47 (30.13) |
Baseline six minute walk distance (meters) | 335.28 (96.47) | 332.15 (92.58) |
Baseline treadmill walking time (minutes) | 7.22 (4.85) | 7.46 (4.12) |
Unless otherwise specified, data shown are means and (standard deviations).
There are 2 participants in the Attention Control group missing baseline pulmonary disease data; there are 2 participants in the SET group missing baseline heart failure data.